The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1.

Saved in:
Bibliographic Details
Title: The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1.
Authors: Cho JH (AUTHOR), Oh DY (AUTHOR), Kim HJ (AUTHOR), Park SY (AUTHOR), Choi HJ (AUTHOR), Kwon SJ (AUTHOR), Lee KS (AUTHOR), Han JS (AUTHOR)
Source: Cancer Letters. Mar2011, Vol. 302 Issue 2, p144-154. 11p.
Database: Academic Search Ultimate
Description
ISSN:03043835